BIOMAT Database Logo BIOMAT Database Logo

Design, Synthesis, and Biological Evaluation of 2-Substituted Aniline Pyrimidine Derivatives as Potent Dual Mer/c-Met Inhibitors. 2024

Daowei Huang, and Ying Chen, and Jixia Yang, and Bingyang Zhao, and Shouying Wang, and Tingting Chai, and Jie Cui, and Xiaolei Zhou, and Zhenhua Shang
School of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang 050018, China.

Mer and c-Met kinases, which are commonly overexpressed in various tumors, are ideal targets for the development of antitumor drugs. This study focuses on the design, synthesis, and evaluation of several 2-substituted aniline pyrimidine derivatives as highly potent dual inhibitors of Mer and c-Met kinases for effective tumor treatment. Compound 18c emerged as a standout candidate, demonstrating robust inhibitory activity against Mer and c-Met kinases, with IC50 values of 18.5 ± 2.3 nM and 33.6 ± 4.3 nM, respectively. Additionally, compound 18c displayed good antiproliferative activities on HepG2, MDA-MB-231, and HCT116 cancer cells, along with favorable safety profiles in hERG testing. Notably, it exhibited exceptional liver microsomal stability in vitro, with a half-life of 53.1 min in human liver microsome. Compound 18c also exhibited dose-dependent cytotoxicity and hindered migration of HCT116 cancer cells, as demonstrated in apoptosis and migration assays. These findings collectively suggest that compound 18c holds promise as a dual Mer/c-Met agent for cancer treatment.

UI MeSH Term Description Entries
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000814 Aniline Compounds Compounds that include the aminobenzene structure. Phenylamine,Phenylamines,Anilines,Compounds, Aniline
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis

Related Publications

Daowei Huang, and Ying Chen, and Jixia Yang, and Bingyang Zhao, and Shouying Wang, and Tingting Chai, and Jie Cui, and Xiaolei Zhou, and Zhenhua Shang
Design, synthesis, and biological evaluation of thieno[2,3-d]pyrimidine derivatives as novel dual c-Met and VEGFR-2 kinase inhibitors.
December 2017, Bioorganic & medicinal chemistry,
Daowei Huang, and Ying Chen, and Jixia Yang, and Bingyang Zhao, and Shouying Wang, and Tingting Chai, and Jie Cui, and Xiaolei Zhou, and Zhenhua Shang
Design, synthesis, and biological evaluation of potent c-Met inhibitors.
September 2008, Journal of medicinal chemistry,
Daowei Huang, and Ying Chen, and Jixia Yang, and Bingyang Zhao, and Shouying Wang, and Tingting Chai, and Jie Cui, and Xiaolei Zhou, and Zhenhua Shang
Design, Synthesis, and Biological Evaluation of Novel Imidazo[1,2-a]pyridine Derivatives as Potent c-Met Inhibitors.
May 2015, ACS medicinal chemistry letters,
Daowei Huang, and Ying Chen, and Jixia Yang, and Bingyang Zhao, and Shouying Wang, and Tingting Chai, and Jie Cui, and Xiaolei Zhou, and Zhenhua Shang
Design and biological evaluation of 3-substituted quinazoline-2,4(1H,3H)-dione derivatives as dual c-Met/VEGFR-2-TK inhibitors.
December 2023, Journal of enzyme inhibition and medicinal chemistry,
Daowei Huang, and Ying Chen, and Jixia Yang, and Bingyang Zhao, and Shouying Wang, and Tingting Chai, and Jie Cui, and Xiaolei Zhou, and Zhenhua Shang
Design, Synthesis, and Biological Evaluation of [1,2,4]triazolo[4,3-a] Pyrazine Derivatives as Novel Dual c-Met/VEGFR-2 Inhibitors.
January 2022, Frontiers in chemistry,
Daowei Huang, and Ying Chen, and Jixia Yang, and Bingyang Zhao, and Shouying Wang, and Tingting Chai, and Jie Cui, and Xiaolei Zhou, and Zhenhua Shang
Design, synthesis and biological evaluation of novel 2-phenyl pyrimidine derivatives as potent Bruton's tyrosine kinase (BTK) inhibitors.
February 2019, MedChemComm,
Daowei Huang, and Ying Chen, and Jixia Yang, and Bingyang Zhao, and Shouying Wang, and Tingting Chai, and Jie Cui, and Xiaolei Zhou, and Zhenhua Shang
Design, synthesis, and biological evaluation of 4-phenoxyquinoline derivatives as potent c-Met kinase inhibitor.
December 2019, Bioorganic & medicinal chemistry letters,
Daowei Huang, and Ying Chen, and Jixia Yang, and Bingyang Zhao, and Shouying Wang, and Tingting Chai, and Jie Cui, and Xiaolei Zhou, and Zhenhua Shang
Design, synthesis and biological evaluation of novel c-Met/HDAC dual inhibitors.
December 2020, Bioorganic & medicinal chemistry letters,
Daowei Huang, and Ying Chen, and Jixia Yang, and Bingyang Zhao, and Shouying Wang, and Tingting Chai, and Jie Cui, and Xiaolei Zhou, and Zhenhua Shang
Design, synthesis and biological evaluation of novel 4-(2-fluorophenoxy)quinoline derivatives as selective c-Met inhibitors.
February 2017, Bioorganic & medicinal chemistry,
Daowei Huang, and Ying Chen, and Jixia Yang, and Bingyang Zhao, and Shouying Wang, and Tingting Chai, and Jie Cui, and Xiaolei Zhou, and Zhenhua Shang
Design, synthesis and biological evaluation of 2-aminopyrimidine derivatives as potent FLT3 inhibitors.
November 2023, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!